RenovoRx, Inc. (RNXT) (CIK 0001574094) (RNXT)
Score window: May. 30, 2025 to May. 29, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Apr. 23, 2026 | CORRESP | Neutral/Informational | Moderate | RenovoRx, Inc. has submitted a correspondence to the SEC requesting the acceleration of the effectiveness of their Registration Statement on Form S-3, filed on April 16, 2026. The… | Read Filing EDGAR |
| Apr. 22, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to RenovoRx, Inc. that they will not review the company's registration statement filed on April 16, 2026. This decision emphasizes the company's responsib… | Read Filing EDGAR |
| Aug. 28, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has completed its review of RenovoRx, Inc.'s Form 10-K for the fiscal year ended December 31, 2024. They remind the company that it is ultimately responsible for the accur… | Read Filing EDGAR |
| Aug. 13, 2025 | CORRESP | Concern from SEC | Moderate | RenovoRx, Inc. submitted a response to the SEC's comment letter regarding their Form 10-K and Form 10-Q filings. The SEC raised concerns about the company's internal control over … | Read Filing EDGAR |
| Jul. 29, 2025 | UPLOAD | Concern from SEC | High | The SEC has reviewed RenovoRx, Inc.'s response to their previous comment letter and has raised additional concerns regarding the company's internal controls over financial reporti… | Read Filing EDGAR |
| Jul. 18, 2025 | CORRESP | Concern from SEC | Moderate | RenovoRx, Inc. has submitted a response to the SEC regarding comments on their Form 10-K and Form 10-Q filings. The SEC raised concerns about the company's internal control over f… | Read Filing EDGAR |
| Jul. 10, 2025 | UPLOAD | Concern from SEC | High | The SEC has conducted a limited review of RenovoRx, Inc.'s recent filings, specifically focusing on the financial statements and related disclosures. They have raised concerns reg… | Read Filing EDGAR |